User profiles for Laurent Azoulay
Laurent AzoulayMcGill university Verified email at mcgill.ca Cited by 10963 |
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
L Azoulay, H Yin, KB Filion, J Assayag, A Majdan… - Bmj, 2012 - bmj.com
RESEARCH Page 1 The use of pioglitazone and the risk of bladder cancer in people with
type 2 diabetes: nested case-control study OPEN ACCESS Laurent Azoulay assistant …
type 2 diabetes: nested case-control study OPEN ACCESS Laurent Azoulay assistant …
[HTML][HTML] A multicenter observational study of incretin-based drugs and heart failure
Background There is concern that antidiabetic incretin-based drugs, including dipeptidyl
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …
peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase …
Glucagon-like peptide 1 receptor agonists and sodium–glucose cotransporter 2 inhibitors and risk of nonalcoholic fatty liver disease among patients with type 2 …
OBJECTIVE To determine whether glucagon-like peptide 1 receptor agonists (GLP-1 RA)
and sodium–glucose cotransporter 2 (SGLT-2) inhibitors, separately, are associated with a …
and sodium–glucose cotransporter 2 (SGLT-2) inhibitors, separately, are associated with a …
[PDF][PDF] Use of statins and the risk of death in patients with prostate cancer
… Oriana Yu, Maria Eberg, Serge Benayoun, Armen Aprikian, Gerald Batist, Samy Suissa,
and Laurent Azoulay … sity; Gerald Batist and Laurent Azoulay, Segal Cancer Centre …
and Laurent Azoulay … sity; Gerald Batist and Laurent Azoulay, Segal Cancer Centre …
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
The prevalence of obesity, of type 2 diabetes mellitus (T2DM), and of cancer are all increasing
globally. The relationships between these diseases are complex, and thus difficult to …
globally. The relationships between these diseases are complex, and thus difficult to …
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
Objective To determine whether the use of angiotensin converting enzyme inhibitors (ACEIs),
compared with use of angiotensin receptor blockers, is associated with an increased risk of …
compared with use of angiotensin receptor blockers, is associated with an increased risk of …
Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study
…, H Yin, OHY Yu, C Renoux, A Bitton, L Azoulay - bmj, 2018 - bmj.com
Objective To assess whether the use of dipeptidyl peptidase-4 inhibitors is associated with
the incidence of inflammatory bowel disease in patients with type 2 diabetes. Design …
the incidence of inflammatory bowel disease in patients with type 2 diabetes. Design …
Metformin and the risk of cancer: time-related biases in observational studies
OBJECTIVE Time-related biases in observational studies of drug effects have been described
extensively in different therapeutic areas but less so in diabetes. Immortal time bias, time-…
extensively in different therapeutic areas but less so in diabetes. Immortal time bias, time-…
Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute …
Objectives To assess whether a double therapy combination consisting of diuretics,
angiotensin converting enzyme inhibitors, or angiotensin receptor blockers with addition of non-…
angiotensin converting enzyme inhibitors, or angiotensin receptor blockers with addition of non-…
Incidence and risk factors of amniotic fluid embolisms: a population-based study on 3 million births in the United States
HA Abenhaim, L Azoulay, MS Kramer… - American journal of …, 2008 - Elsevier
OBJECTIVE: Amniotic fluid embolism (AFE) is a condition occurring during delivery that can
lead to severe maternal morbidity and mortality. Given the rarity of its occurrence, current …
lead to severe maternal morbidity and mortality. Given the rarity of its occurrence, current …